Topic List : Infectious Disease
Trial tests antibody drug as COVID-19 treatment
Stanford Medicine has joined a multisite clinical trial testing antibodies designed to block the coronavirus from infecting human cells and shorten the course of the illness.
Advising schools on COVID-19 tests
Stanford Medicine faculty are helping Bay Area school districts determine how to access COVID-19 testing and are advising the Los Angeles Unified School District on its testing strategy.
COVID-19 course for global health workers
Health care workers around the world can take a five-hour course, created by Stanford emergency physicians, on caring for COVID-19 patients and preventing the spread of the disease.
Modeling contact tracing
Researchers have developed a mathematical model to examine the potential of contact tracing to reduce the spread of the coronavirus.
Immune deviations seen in severe COVID-19 cases
A Stanford study shows that in severely ill COVID-19 patients, “first-responder” immune cells, which should react immediately to signs of viruses or bacteria in the body, instead respond sluggishly.
Vaping linked to higher COVID-19 risk
Data collected in May shows that teenagers and young adults who vape face a much higher risk of COVID-19 than their peers who do not vape, Stanford researchers found.
Stanford can begin pooled testing for COVID-19
A Stanford Medicine test for the coronavirus has been validated for pooled testing. This method greatly increases testing capacity and conserves testing resources, which continue to be in short supply.
How pathogens put the brakes on immune response
Researchers at the Stanford School of Medicine have discovered that cells infected by viruses or bacteria send out a “don’t eat me” signal to avoid attack by the body’s immune system.
Anthony Fauci talks COVID-19 with dean
The nation’s top infectious disease expert spoke with School of Medicine Dean Lloyd Minor about the challenges posed by COVID-19, the hope for emerging vaccines and treatments, and what’s still unknown about the virus.
Study to look at oral drug for COVID-19
Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19.